Altaris Acquires Kindeva Drug Delivery from 3M

Altaris Capital Partners, LLC (“Altaris”) announced Friday that it has completed the acquisition of Kindeva Drug Delivery, formerly known as 3M Drug Delivery Systems, from 3M Company (NYSE: MMM) for total consideration of $650 million. The business, headquartered outside St. Paul, Minnesota, is a leading global contract development and manufacturing organization (CDMO) that specializes in solving complex drug delivery challenges for its pharmaceutical and biotechnology customers using unique inhalation, transdermal, and microneedle drug delivery technologies. “We are excited to be partnering with 3M and the Kindeva team in this corporate carve-out transaction,” said George Aitken-Davies, Managing Director of Altaris. “We believe Kindeva is well positioned to build on its successful track record as a leading provider of drug delivery technologies.”

Read the full article: Altaris Acquires Kindeva Drug Delivery from 3M //


Scroll to Top